Related Experiment Video
Updated: Aug 13, 2026

Generation of Human 3D Lung Tissue Cultures (3D-LTCs) for Disease Modeling
Published on: February 12, 2019
[Rare pulmonary (alveolar) diseases--clinico-morphological and etiopathogenic aspects]
Abstract:
Bearing in mind the exceptional rarity of the following three pulmonary diseases: pulmonal microlythiasis, proteinosis and primary idiopathic amyloidosis, a review of the latest publications in the international scientifical literature about their ethiology and pathogenesis has been made. In this context, the latest data concerning the role of pulmonary surfactant in their pathogenesis has been outlined. The description and re-iteration of the scanty information available about these conditions will expand the knowledge of specialists in pulmology and of general practitioners in particular who are the first to encounter these particularly seldom occurring, and for this reason insufficiently investigated, diseases. The new reports regarding the structure, production and recycling of pulmonary surfactant clarify to a certain extent the ethiology and pathogenesis of the diseases looked upon not long ago as conditions of unsettled ethiology.
Insights
This review explores the rare pulmonary diseases pulmonal microlythiasis, proteinosis, and primary idiopathic amyloidosis. New findings on pulmonary surfactant offer insights into their causes and development.
Area of Science:
- Pulmonology
- Pathogenesis Research
- Rare Lung Diseases
Context:
- Focuses on three exceptionally rare pulmonary conditions: pulmonal microlythiasis, proteinosis, and primary idiopathic amyloidosis.
- Highlights the limited existing literature and the need for increased understanding among specialists and general practitioners.
- Emphasizes the diagnostic challenges posed by the rarity and insufficient investigation of these diseases.
Purpose:
- To review the latest international scientific literature on the etiology and pathogenesis of these rare pulmonary diseases.
- To outline recent data on the role of pulmonary surfactant in the pathogenesis of these conditions.
- To consolidate and disseminate existing knowledge, aiding in the diagnosis and management of these uncommon diseases.
Summary:
- Reviews the etiology and pathogenesis of pulmonal microlythiasis, proteinosis, and primary idiopathic amyloidosis.
- Discusses the role of pulmonary surfactant, including its structure, production, and recycling, in the development of these diseases.
- Integrates new research findings to clarify the previously unsettled etiology of these rare lung disorders.
Impact:
- Enhances the knowledge base for pulmonologists and general practitioners regarding rare pulmonary diseases.
- Provides a foundation for further research into the mechanisms underlying these conditions.
- Aims to improve the recognition and clinical management of patients with pulmonal microlythiasis, proteinosis, and primary idiopathic amyloidosis.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Atelectasis II: Pathophysiology
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

